PHARMACOVIGILANCE GUIDELINES

被引：0
|
作者：
LEWIS, S
机构：
来源：
LANCET | 1994年 / 343卷 / 8896期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：535 / 535
页数：1
相关论文
共 50 条
  • [31] The history of pharmacovigilance
    Caron, Jacques
    Rochoy, Michael
    Gaboriau, Louise
    Gautier, Sophie
    THERAPIE, 2016, 71 (02): : 129 - 134
  • [32] A Review of Pharmacovigilance
    Campbell, J. E.
    Gossell-Williams, M.
    Lee, M. G.
    WEST INDIAN MEDICAL JOURNAL, 2014, 63 (07): : 771 - 774
  • [33] The Future of Pharmacovigilance
    Arlett, P.
    DRUG SAFETY, 2015, 38 (10) : 938 - 938
  • [34] TRANSNATIONAL PHARMACOVIGILANCE
    CHOO, V
    LANCET, 1993, 342 (8874): : 797 - 798
  • [35] The Importance Of Pharmacovigilance
    Shankar, P. R.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2008, 2 (06) : 1246 - 1247
  • [36] PHARMACOVIGILANCE, A NECESSITY
    IMBS, JL
    JOURNAL DE MEDECINE DE STRASBOURG, 1982, 13 (08): : 601 - 601
  • [37] PHARMACOVIGILANCE IN GERMANY
    THURMANN, P
    HARDER, S
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1994, 32 (03) : 159 - 159
  • [38] Pharmacovigilance in Perspective
    Ronald H. B. Meyboom
    Antoine C. G. Egberts
    Frank W. J. Gribnau
    Yechiel A. Hekster
    Drug Safety, 1999, 21 : 429 - 447
  • [39] Transparency in pharmacovigilance
    van Grootheest, AC
    Kabel, JS
    van Puijenbroek, E
    DRUG SAFETY, 2005, 28 (10) : 936 - 936
  • [40] Bismuth and pharmacovigilance
    Trenque, Thierry
    THERAPIE, 2021, 76 (05): : 383 - 384
12345